WASHINGTON — A U.S. Senate panel has scheduled a hearing to examine the use of artificial intelligence in mental health care technologies, including systems that record and transcribe therapy sessions, according to committee notices released this month. Lawmakers said the hearing will focus on privacy protections, patient consent requirements and the growing use of AI tools in healthcare settings.
Committee officials said the hearing is expected to bring together technology developers, healthcare providers, privacy experts and mental health professionals. Details regarding the full witness list and the scope of testimony remain unclear. Senate staff said the proceeding is intended to assess how AI tools are being deployed in clinical environments and whether existing safeguards adequately protect patient information. Officials did not immediately provide additional details.
The hearing comes as AI-powered transcription platforms are being adopted by some therapists, hospitals and healthcare networks. Developers of the technology say automated transcription can reduce administrative workloads, improve record-keeping and allow clinicians to spend more time with patients. Several healthcare technology companies have promoted AI-assisted documentation tools as a means of increasing efficiency while maintaining compliance with medical privacy requirements.
Lawmakers from both parties have increasingly scrutinized AI applications involving sensitive personal information. Previous Senate hearings on artificial intelligence have examined issues including consumer protection, online safety and the potential risks posed by AI systems operating with limited oversight. Senate committees have also explored the role of AI in healthcare, productivity and public services. According to committee materials, recent hearings have emphasized balancing innovation with safety and accountability.
Privacy advocates and some mental health professionals have raised concerns about the recording and storage of highly sensitive therapy conversations. Discussions among therapists and patients have highlighted questions regarding data retention, third-party access to transcripts and informed consent procedures when AI tools are used during counseling sessions. Others have argued that clear disclosure requirements and patient choice are essential safeguards when such technologies are deployed.
Industry representatives have said AI transcription systems can be configured to meet healthcare privacy standards and that patient consent remains a central component of responsible deployment. Some providers have stated that the technology is used only to assist with documentation and not to make independent clinical decisions.
Senate officials said the hearing will proceed later this month. As of Tuesday, no legislation directly tied to the hearing had been formally announced, and committee staff said additional information would be released ahead of the session. Details regarding any potential regulatory proposals remain unclear.
